Both BASMATI (nanomaterial ink scale-up) and IMPETUS (electrochemical strip printing) centre on Gwent's core commercial capability of manufacturing printable functional materials.
GWENT ELECTRONIC MATERIALS LIMITED
UK SME manufacturing functional and conductive inks for printed electronics, with applied expertise in paper-based electrochemical biosensors and diagnostic test strips.
Their core work
Gwent Electronic Materials is a specialist manufacturer of functional inks, conductive pastes, and coatings for printed electronics, based in Pontypool, Wales. Their core business is formulating materials that allow electronic functionality — conductivity, resistivity, electrochemical activity — to be deposited onto substrates like paper, film, and flexible surfaces through standard printing processes. In the H2020 programme, they contributed materials and printing process expertise: first to scale up nanomaterial-based inks (BASMATI), then to manufacture paper-based electrochemical test strips for medical diagnostics (IMPETUS). They act as the industrial bridge between advanced materials research and manufacturable printed electronics products.
What they specialise in
BASMATI addressed scaling inks for printing processes, while IMPETUS involved a pilot line for printing electrochemical test strips — both require industrial printing process knowledge.
IMPETUS (2018–2022) introduced keywords including paper-based analytical devices, electrochemical biosensors, and lateral flow tests, marking an entry into printed diagnostics.
BASMATI explicitly targeted bringing innovation by scaling up nanomaterials and inks for printing, a materials engineering challenge distinct from their routine production work.
How they've shifted over time
In their first H2020 project (BASMATI, 2015–2017), Gwent's contribution was upstream: scaling the production of nanomaterial-based inks, a manufacturing and process engineering challenge close to their core business. By IMPETUS (2018–2022), the application layer had shifted entirely toward healthcare — paper-based analytical devices, point-of-care testing, and lateral flow strips — with their printing technology now serving as the manufacturing backbone for diagnostic products. The trajectory is a deliberate move from material supplier to application-specific component manufacturer, with medical diagnostics as the destination sector.
Gwent is positioning its printed electronics manufacturing capability as infrastructure for the medical diagnostics market, particularly low-cost paper-based point-of-care devices — a sector with strong commercial growth pressure post-2020.
How they like to work
Gwent has never led an H2020 project, always joining as a specialist industrial participant. Despite only two projects, they accumulated 29 unique consortium partners across 7 countries, which points to involvement in large, multi-partner consortia where they fill a defined materials or manufacturing role rather than driving the scientific agenda. This pattern is typical of an industrial SME that enters consortia as a technology provider — bringing a specific commercial capability that academic or research-heavy consortia cannot supply themselves.
With 29 unique partners across 7 countries from just two projects, Gwent has a notably wide network for a two-project participant, suggesting both consortia were large and internationally distributed. Their geographic reach is European, consistent with UK participation in H2020 before Brexit transition.
What sets them apart
Gwent Electronic Materials occupies a rare industrial niche: a commercial manufacturer of functional inks that actively participates in EU research consortia, something most materials suppliers do not do. This combination means they can translate laboratory-scale ink formulations into manufacturable products — the capability gap that most research projects fail at. For consortia developing printed sensors, diagnostics, or flexible electronics, they offer both the materials and the pilot-scale printing process know-how in a single SME partner.
Highlights from their portfolio
- BASMATITheir largest project by funding (€228,863) and their entry into EU collaborative R&D, focused on scaling nanomaterial-based inks — directly aligned with Gwent's commercial manufacturing mission.
- IMPETUSMarks Gwent's pivot into medical diagnostics manufacturing via a pilot line for paper-based electrochemical test strips, signalling a strategic move toward the high-value point-of-care testing market.